RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

Go back to RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

RxSight Inc. (RXST) PT Lowered to $6.50 at BofA Securities

July 7, 2026 12:24 PM EDT

BofA Securities analyst Craig Bijou lowered the price target on RxSight Inc. (NASDAQ: RXST) to $6.50 (from $8.00) while maintaining a Underperform rating.

The analyst comments "RXST pre-Ad preliminary Q2 sales of $27m vs Street of $32m and lowered 2026 guidance by $13m at... More